Who Can Take the OCN Exam: ONCC’s 2026 Eligibility Rules

The Zarit Burden Interview is a validated assessment tool widely utilized in oncology and palliative care to measure subjective caregiver burden and perceived emotional, physical, and financial strain. It assists the interprofessional team in identifying caregivers requiring targeted supportive interventions or respite services. The Edmonton Symptom Assessment System is designed to evaluate physical and psychological symptom severity directly reported by the patient, such as pain, fatigue, nausea, and depression, rather than family caregiver strain. The Palliative Performance Scale measures a patient's functional performance, ambulation, activity level, self-care ability, intake, and conscious state to guide prognosis and palliative needs. The Functional Assessment of Anorexia/Cachexia Therapy evaluates quality of life related specifically to nutritional status, weight loss, and appetite changes in patients with cancer. Recognizing family caregiver strain through validated measures ensures proactive referral to community resources, social work counseling, and caregiver support programs before severe burnout occurs.

Febrile neutropenia is a life-threatening oncologic emergency characterized by an absolute neutrophil count below 500/mcL and a single oral temperature of 38.3 degrees Celsius or sustained temperature of 38.0 degrees Celsius. National guidelines recommend that empiric broad-spectrum intravenous antibiotic coverage be initiated within 60 minutes of triage or presentation. Rapid administration halts potential progression to septic shock and reduces mortality, as neutropenic patients lack the normal host inflammatory defenses to contain bacteremia. Initiating therapy within 30 minutes is an admirable institutional goal but exceeds the accepted standard metric of one hour, often being unfeasible when blood cultures must first be obtained. A timeframe of 90 minutes delays critical antimicrobial coverage and misses the guideline target. Waiting 120 minutes is unsafe because bacterial doubling times in an immunocompromised host can lead to profound hemodynamic instability and fatal septic complications before systemic drug levels are established.

Fatal ascending myeloradiculopathy is the devastating consequence of accidental intrathecal vincristine administration. Vincristine is a vinca alkaloid strictly designated for intravenous use only; when introduced directly into the cerebrospinal fluid, it causes progressive axonal destruction, extensive radiculopathy, ascending paralysis, and ultimately death from encephalopathy and respiratory arrest. Severe hemorrhagic cystitis is a characteristic toxic effect of oxazaphosphorine alkylating agents, such as ifosfamide and high-dose cyclophosphamide, mediated by the urinary bladder metabolite acrolein rather than vinca alkaloids. Acute cerebellar ataxia is a recognized neurological toxicity associated with high-dose cytarabine administration, particularly in patients with renal impairment, but does not stem from intrathecal vincristine. Irreversible pulmonary fibrosis is a classic cumulative toxicity associated with bleomycin and busulfan therapy, presenting as insidious restrictive lung disease rather than acute neurotoxicity. Because inadvertent intrathecal administration of vincristine is virtually always fatal, safety mandates require vincristine to be prepared and dispensed in an intravenous minibag rather than a syringe to virtually eliminate the risk of accidental intrathecal injection.

Topical dimethyl sulfoxide acts primarily as a free-radical scavenger to limit local tissue damage following an anthracycline extravasation. Anthracyclines such as doxorubicin generate cytotoxic reactive oxygen species that cause progressive, severe tissue ulceration and necrosis; dimethyl sulfoxide penetrates tissue rapidly to neutralize these toxic free radicals, reduce inflammation, and facilitate drug clearance. Chelation of iron ions describes the mechanism of systemic dexrazoxane, which displaces anthracyclines from iron to prevent free-radical formation, rather than the topical action of dimethyl sulfoxide. Hydrolysis of tissue hyaluronan is the mechanism of hyaluronidase, an enzyme used to degrade interstitial matrix barriers and enhance systemic dispersion of extravasated vinca alkaloids and taxanes, but it is not indicated for anthracyclines. Constriction of local capillaries describes a physiological response achieved through the application of cold thermal compresses, which are often used alongside topical dimethyl sulfoxide to limit drug spread, but this does not represent the pharmacological mechanism of dimethyl sulfoxide itself. Understanding these distinct antidote mechanisms ensures proper institutional extravasation protocol management and prevents severe tissue destruction.

Performing routine venipunctures should be strictly avoided in an extremity affected by secondary lymphedema, along with blood pressure measurements, finger sticks, and intramuscular injections. Disruptions to skin integrity and localized mechanical trauma in an arm with compromised lymphatic drainage can increase the risk of introducing microbial pathogens and precipitating severe cellulitis or worsening lymph fluid accumulation. In contrast, applying graduated compression garments is an evidence-based standard of care that promotes lymphatic fluid return and helps maintain limb volume reductions achieved during complete decongestive therapy. Elevating the extremity above heart level utilizes gravity to assist passive lymphatic flow, reduce hydrostatic capillary pressure, and alleviate interstitial fluid pooling, making it an appropriate recommended supportive measure. Encouraging gentle exercise stimulates skeletal muscle pump activity, which actively propels lymphatic fluid through remaining functional collateral channels without overloading the compromised lymphatic bed. Consequently, while compression, elevation, and tailored exercise facilitate fluid clearance, invasive vascular procedures can worsen lymphedema.